Astrazeneca plc — RNS

Regulatory news across AZN

Date	Time	Date	TitleTitle (filtered)	Source
20/12/21	07:05:06	20 Dec 2021	Tezspire approved in the US for severe asthma	Tezspire approved in the US for severe asthma	RNS
20/12/21	07:00:07	20 Dec 2021	Saphnelo recommended for EU approval for SLE	Saphnelo recommended for EU approval for SLE	RNS
15/12/21	15:00:01	15 Dec 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
09/12/21	07:00:06	9 Dec 2021	Evusheld US FDA EUA	Evusheld US FDA EUA	RNS
07/12/21	07:00:04	7 Dec 2021	AstraZeneca, Ionis to collaborate on eplontersen	AstraZeneca, Ionis to collaborate on eplontersen	RNS
01/12/21	15:00:06	1 Dec 2021	Block listing Interim Review	Block listing Interim Review	RNS
01/12/21	15:00:06	1 Dec 2021	Total Voting Rights	Total Voting Rights	RNS
30/11/21	07:00:06	30 Nov 2021	Lynparza granted FDA Priority Review for OlympiA	Lynparza granted FDA Priority Review for OlympiA	RNS
15/11/21	16:00:05	15 Nov 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
12/11/21	07:00:02	12 Nov 2021	AZN: Year to date and Q3 2021 results	AZN: Year to date and Q3 2021 results	RNS
01/11/21	15:00:01	1 Nov 2021	Total Voting Rights	Total Voting Rights	RNS
01/11/21	07:00:12	1 Nov 2021	AstraZeneca to transfer rights to Eklira, Duaklir	AstraZeneca to transfer rights to Eklira, Duaklir	RNS
25/10/21	07:00:14	25 Oct 2021	Imfinzi improved survival in biliary tract cancer	Imfinzi improved survival in biliary tract cancer	RNS
18/10/21	07:00:06	18 Oct 2021	AZ recommends ADS holders reject mini-tender offer	AZ recommends ADS holders reject mini-tender offer	RNS
15/10/21	07:00:03	15 Oct 2021	Imfinzi & tremelimumab improved OS in liver cancer	Imfinzi & tremelimumab improved OS in liver cancer	RNS
11/10/21	07:00:10	11 Oct 2021	AZD7442 PhIII trial positive in COVID outpatients	AZD7442 PhIII trial positive in COVID outpatients	RNS
04/10/21	07:00:07	4 Oct 2021	Enhertu granted BTD for breast cancer	Enhertu granted BTD for breast cancer	RNS
01/10/21	15:00:02	1 Oct 2021	Total Voting Rights	Total Voting Rights	RNS
30/09/21	16:00:07	30 Sept 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
29/09/21	07:00:09	29 Sept 2021	AstraZeneca to fully acquire Caelum Biosciences	AstraZeneca to fully acquire Caelum Biosciences	RNS
28/09/21	07:00:05	28 Sept 2021	Saphnelo approved in Japan for SLE	Saphnelo approved in Japan for SLE	RNS
24/09/21	07:00:05	24 Sept 2021	Lynparza PROpel trial meets primary endpoint	Lynparza PROpel trial meets primary endpoint	RNS
23/09/21	07:00:08	23 Sept 2021	Board Committee Change	Board Committee Change	RNS
23/09/21	07:00:08	23 Sept 2021	New Sustainability Committee of the Board	New Sustainability Committee of the Board	RNS
21/09/21	07:00:09	21 Sept 2021	AstraZeneca $360m Irish manufacturing investment	AstraZeneca $360m Irish manufacturing investment	RNS
20/09/21	07:00:08	20 Sept 2021	Enhertu reduced risk of disease progression by 72%	Enhertu reduced risk of disease progression by 72%	RNS
09/09/21	16:00:04	9 Sept 2021	Imfinzi improves survival in NSCLC in POSEIDON	Imfinzi improves survival in NSCLC in POSEIDON	RNS
09/09/21	07:00:05	9 Sept 2021	PT027 PhIII asthma trials met primary endpoints	PT027 PhIII asthma trials met primary endpoints	RNS
03/09/21	07:00:06	3 Sept 2021	Ultomiris approved in EU for children with PNH	Ultomiris approved in EU for children with PNH	RNS
01/09/21	15:00:06	1 Sept 2021	Total Voting Rights	Total Voting Rights	RNS
26/08/21	07:05:00	26 Aug 2021	Forxiga approved in Japan for CKD	Forxiga approved in Japan for CKD	RNS
26/08/21	07:00:02	26 Aug 2021	ALXN1840 Wilson Phase III met primary endpoint	ALXN1840 Wilson Phase III met primary endpoint	RNS
20/08/21	07:05:04	20 Aug 2021	Update on Ultomiris Phase III ALS trial	Update on Ultomiris Phase III ALS trial	RNS
20/08/21	07:00:09	20 Aug 2021	AZD7442 prophylaxis trial met primary endpoint	AZD7442 prophylaxis trial met primary endpoint	RNS
16/08/21	15:00:01	16 Aug 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS

Showing 451–485 of 485 announcements